drugset / Trial / NCT01640496

Vitamin D Treatment in Ulcerative Colitis

NCT01640496

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test blood and tissue samples of people with Ulcerative Colitis (UC) to see what effects Vitamin D3 may have on the immune system. This research is being done because it could lead to the development of new treatment for people with Inflammatory Bowel Disease (IBD).

Timeline

Start
2012-07
Primary completion
2014-06
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 3000 iu

Indications